Medical Abortion Provision by Pharmacies and Drug Sellers in Low- and Middle-Income Countries: A Systematic Review

Self-managed health   |   31 March 2018 

Share






Copied


Pharmacies play an important and growing role in women’s access to medical abortion. This systematic review assesses the level and quality of pharmacy provision of medical abortion in low- and middle-income countries.

The review also identified interventions to improve quality of pharmacy provision. The review identified 22 studies from 16 countries reporting on level and quality of medical abortion provision through pharmacies, and three intervention studies. Despite widespread awareness and provision of medical abortion drugs by pharmacies, even in legally restricted contexts, most studies found that pharmacy workers had poor knowledge of effective regimens. Evidence on interventions to improve pharmacy and drug shop provision of medical abortion was limited and generally low quality, but indicated that training could be effective in improving knowledge. The results of this systematic review suggest that programmes should focus on the development and rigorous evaluation of innovative interventions to improve women’s access to information about self-management of medical abortion in low- and middle-income countries.


Share






Copied

Related posts

Press release


4 February 2025   |   3 min read

MSI Reproductive Choices’ comment on attacks on USAID

MSI’s Senior Director for US External Affairs comments on recent events related to the US Agency for International

Resource


4 February 2025

What is a CYP?

Learn more about Couple Years of Protection – a measure that estimates the protection from pregnancy provided by

Research


18 December 2024

External Impact Assessment of MSI’s Public Sector Strengthening Model in Nigeria

The research paper concluded that “the MSI PSS model has had a transformative impact on reproductive health